Home-based versus clinic-based specimen collection in the management of Chlamydia trachomatis and Neisseria gonorrhoeae infections

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 9, 2015, Pages

  Fajardo Bernal, Luisa ^a   Aponte Gonzalez, Johanna ^a   Vigil, Patrick ^b   Angel Müller, Edith ^a   Rincon, Carlos ^c   Gaitán, Hernando G ^a   Low, Nicola ^d  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b Central Washington Family Medicine   (United States)

^c PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDIASIS; CONFIDENCE INTERVAL; ECONOMIC ASPECT; FOLLOW UP; GONORRHEA; HIGH RISK POPULATION; HOME; HOSPITAL; HUMAN; INFECTION RISK; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MEN WHO HAVE SEX WITH MEN; OUTCOME ASSESSMENT; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SAFETY; SAMPLING; SEX WORKER; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SYSTEMATIC REVIEW; URINE SAMPLING; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; ISOLATION AND PURIFICATION; MALE; META ANALYSIS; NEISSERIA GONORRHOEAE; PROCEDURES; SELF CARE; STATISTICS AND NUMERICAL DATA;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; GONORRHEA; HUMANS; MALE; NEISSERIA GONORRHOEAE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SAFETY; SELF CARE; SPECIMEN HANDLING;

EID: 84964693564     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011317.pub2     Document Type: Review

References (66)

1. Andersen B, Ostergaard L, Moller JK, Olesen F. Home sampling versus conventional contact tracing for detecting Chlamydia trachomatis infection in male partners of infected women: randomised study. BMJ (Clinical research ed) 1998;316(7128):350-1. [PUBMED: 9487169]
2. Cook RL, Ostergaard L, Hillier SL, Murray PJ, Chang CC, Comer DM, et al. Home screening for sexually transmitted diseases in high-risk young women: randomised controlled trial. Sexually Transmitted Infections 2007;83(4):286-91. [PUBMED: 17301105]
3. Götz HM, Wolfers MEG, Luijendijk A, van den Broek IVF. Retesting for genital Chlamydia trachomatis among visitors of a sexually transmitted infections clinic: Randomized intervention trial of home-versus clinic-based recall. BMC Infectious Diseases 2013;13:239. [PUBMED: 23705624]
4. Graseck AS, Secura GM, Allsworth JE, Madden T, Peipert JF. Home compared with clinic-based screening for sexually transmitted infections: A randomized controlled trial. Obstetrics and Gynecology 2010;116(6):1311-8. [PUBMED: 21099596]
5. Jones HE, Altini L, de Kock A, Young T, van de Wijgert JH. Home-based versus clinic-based self-sampling and testing for sexually transmitted infections in Gugulethu, South Africa: randomised controlled trial. Sexually Transmitted Infections 2007;83(7):552-7. [PUBMED: 17901084]
6. Lippman SA, Jones HE, Luppi CG, Pinho AA, Veras MAMS, Van De Wijgert JHHM. Home-based self-sampling and self-testing for sexually transmitted infections: Acceptable and feasible alternatives to provider-based screening in low-income women in Sao Paulo, Brazil. Sexually Transmitted Diseases 2007;34(7):421-8. [PUBMED: 17091118]
7. Ostergaard L, Andersen B, Olesen F, Moller JK. Efficacy of home sampling for screening of Chlamydia trachomatis: randomised study. BMJ (Clinical research ed) 1998;317(7150):26-7. [PUBMED: 9651263]
8. Ostergaard L, Andersen B, Moller JK, Olesen F, Worm AM. Managing partners of people diagnosed with Chlamydia trachomatis: A comparison of two partner testing methods. Sexually Transmitted Infections 2003;79(5):358-62. [PUBMED: 14573827]
9. Reagan MM, Xu H, Shih SL, Secura GM, Peipert JF. A randomized trial of home versus clinic-based sexually transmitted disease screening among men. Sexually Transmitted Diseases 2012;39(11):842-7. [PUBMED: 23064532]
10. Xu F, Stoner BP, Taylor SN, Mena L, Tian LH, Papp J, et al. Use of home-obtained vaginal swabs to facilitate rescreening for Chlamydia trachomatis infections: Two randomized controlled trials. Obstetrics and Gynecology 2011;118(2 PART 1):231-9. [PUBMED: 21775837]
11. Andersen B, Olesen F, Moller JK, Ostergaard L. Population-based strategies for outreach screening of urogenital Chlamydia trachomatis infections: a randomized, controlled trial. Journal of Infectious Diseases 2002;185(2):252-8. [PUBMED: 11807700]
12. Andersen B, Van Valkengoed I, Sokolowski I, Moller JK, Ostergaard L, Olesen F. Impact of intensified testing for urogenital Chlamydia trachomatis infections: A randomised study with 9-year follow-up. Sexually Transmitted Infections 2011;87(2):156-61. [PUBMED: 21097811]
13. Buhrer-Skinner M, Muller R, Buettner PG, Gordon R, Debattista J. Improving Chlamydia trachomatis retesting rates by mailed self-collection kit. Sexual Health 2011;8(2):248-50. [PUBMED: 21592441]
14. Emmerton L, Buhrer Skinner M, Gardiner E, Nissen L, Debattista J. A trial of the distribution of chlamydia self-collection postal specimen kits from Australian community pharmacies. Sexual Health 2011;8(1):130-2. [PUBMED: 21371398]
15. Falk L, Hegic S, Wilson D, Wirehn A-B. Home-sampling as a tool in the context of Chlamydia trachomatis partner notification: a randomized controlled trial. Acta Dermato-Venereologica 2014;94(1):72-4. [PUBMED: 23807656]
16. Gray RH, Wawer MJ, Girdner J, Sewankambo NK, Serwadda D, Meehan M, et al. Use of self-collected vaginal swabs for detection of Chlamydia trachomatis infection. Sexually Transmitted Diseases 1998;25(8):450. [PUBMED: 9773442]
17. Klovstad H, Natas O, Tverdal A, Aavitsland P. Systematic screening with information and home sampling for genital Chlamydia trachomatis infections in young men and women in Norway: A randomized controlled trial. BMC Infectious Diseases 2013;13:30. [PUBMED: 23343391]
18. Ostergaard LJ, Andersen BS, Olesen F, Moller JK. Detection of Chlamydia trachomatis infection among young people. The effect of home-sampling and mailing the samples. Ugeskr Laeger 1999;161(32):4514-8. [PUBMED: 10477967]
19. Ostergaard L, Andersen B, Moller JK, Olesen F. Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: A cluster-randomized 1-year follow-up study. Clinical Infectious Diseases 2000;31(4):951-7. [PUBMED: 11049776]
20. Scholes D, Heidrich FE, Yarbro P, Lindenbaum JE, Marrazzo JM. Population-based outreach for chlamydia screening in men: Results from a randomized trial. Sexually Transmitted Diseases 2007;34(11):837-9. [PUBMED: 17538514]
21. Sparks R, Helmers JR, Handsfield HH, Totten PA, Holmes KK, Wroblewski JK, et al. Rescreening for gonorrhea and chlamydial infection through the mail: a randomized trial. Sexually Transmitted Diseases 2004;31(2):113-6. [PUBMED: 14743074]
22. Van Valkengoed IGM, Morre SA, Meijer C, Van Den Brule AJC, Boeke AJP. Do questions on sexual behaviour and the method of sample collection affect participation in a screening programme for asymptomatic Chlamydia trachomatis infections in primary care?. International Journal of STD & AIDS 2002;13(1):36-8. [PUBMED: 11802928]
23. Apoola A, Beardsley J. Does the addition of a urine testing kit to use of contact slips increase the partner notification rates for genital chlamydial infection?. International Journal of STD and AIDS 2009;20(11):775-7. [PUBMED: 19833688]
24. De Barbeyrac B, Rahib D, De Diego S, Le Roy C, Bebear C, Lydie N. Internet testing for chlamydia trachomatis in France in 2012. Sexually Transmitted Infections 2013;89(Suppl 1):A155-A156. [DOI: 10.1136/sextrans-2013-051184.0485]
25. Smith KS, Hocking JS, Chen M, Fairley CK, McNulty A, Read P, et al. Rationale and design of REACT: A randomised controlled trial assessing the effectiveness of home-collection to increase chlamydia retesting and detect repeat positive tests. BMC Infectious Diseases 2014;14:223. [PUBMED: 24758169]
26. Blandford JM, Gift TL. Productivity losses attributable to untreated chlamydial infection and associated pelvic inflammatory disease in reproductive-aged women. Sexually Transmitted Diseases 2006;33(10 Suppl):S117-21. [PUBMED: 17003678]
27. Carey AJ, Beagley KW. Chlamydia trachomatis, a hidden epidemic: effects on female reproduction and options for treatment. American Journal of Reproductive Immunology 2010;63(6):576-86. [PUBMED: 20192953]
28. Chernesky MA, Hook EW3, Martin DH, Lane J, Johnson R, Jordan JA, et al. Women find it easy and prefer to collect their own vaginal swabs to diagnose Chlamydia trachomatis or Neisseria gonorrhoeae infections. Sexually Transmitted Diseases 2005;32(12):729-33. [PUBMED: 16314768]
29. Chesson HW, Collins D, Koski K. Formulas for estimating the costs averted by sexually transmitted infection (STI) prevention programs in the United States. Cost Effectiveness and Resource Allocation 2008;6:10. [DOI: 10.1186/1478-7547-6-10]
30. Deeks JJ, Altman DG, Bradburn MJ. Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis. In: M. Egger, G. D. Smith, D. G. Altman editor(s). Systematic Reviews in Health Care: Meta-Analysis in Context. Second Edition. London, UK: BMJ Publishing Group, 2001. [DOI: 10.1002/9780470693926.ch15]
31. Gaydos CA, Theodore M, Dalesio N, Wood BJ, Quinn TC. Comparison of three nucleic acid amplification tests for detection of Chlamydia trachomatis in urine specimens. Journal of Clinical Microbiology 2004;42(7):3041-5. [PUBMED: 15243057]
32. Gaydos CA, Rizzo-Price PA, Barnes M, Dwyer K, Wood BJ, Hogan MT. The use of focus groups to design an internet-based program for chlamydia screening with self-administered vaginal swabs: what women want. Sexual Health 2006;3(4):209-15. [PUBMED: 17112429]
33. Graseck AS, Shih SL, Peipert JF. Home versus clinic-based specimen collection for Chlamydia trachomatis and Neisseria gonorrhoeae. Expert Review of Anti-infective Therapy 2011;9(2):183-94. [PUBMED: 21342066]
34. Götz HM, van Bergen JE, Veldhuijzen IK, Hoebe CJ, Broer J, Coenen AJ, et al. Lessons learned from a population-based chlamydia screening pilot. International Journal of STD & AIDS 2006;17(12):826-30. [PUBMED: 17212860]
35. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60. [PUBMED: 12958120]
36. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
37. Hobbs MM, van der Pol B, Totten P, Gaydos CA, Wald A, Warren T, et al. From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections. Sexually Transmitted Diseases 2008;35(1):8-13. [PUBMED: 18157061]
38. IntHout J, Ioannidis JP, Borm GF, Goeman JJ. Small studies are more heterogeneous than large ones: a meta-meta-analysis. Journal of clinical epidemiology 2015;68(8):860-9. [PUBMED: 25959635]
39. Low N, Broutet N, Adu-Sarkodie Y, Barton P, Hossain M, Hawkes S. Global control of sexually transmitted infections. Lancet 2006;368(9551):2001-16. [PUBMED: 17141708]
40. Low N. Screening programmes for chlamydial infection: when will we ever learn?. BMJ (Clinical research ed.) 2007;334(7596):725-8. [PUBMED: 17413173]
41. Macleod J, Salisbury C, Low N, McCarthy A, Sterne JA, Holloway A, et al. Coverage and uptake of systematic postal screening for genital Chlamydia trachomatis and prevalence of infection in the United Kingdom general population: cross sectional study. BMJ (Clinical research ed.) 2005;330(7497):940. [PUBMED: 15809231]
42. Manhart LE, Holmes KK. Randomized controlled trials of individual-level, population-level, and multilevel interventions for preventing sexually transmitted infections: what has worked?. Journal of Infectious Diseases 2005;191 Suppl 1:S7-24. [PUBMED: 15627233]
43. Masek BJ, Arora N, Quinn N, Aumakhan B, Holden J, Hardick A, et al. Performance of three nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an Internet-based screening program. Journal of Clinical Microbiology 2009;47(6):1663-7. [PUBMED: 19386838]
44. Mayaud P, Mabey D. Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challenges. Sexually Transmitted Infections 2004;80(3):174-82. [PUBMED: 15169997]
45. Mehta SD, Bishai D, Howell MR, Rothman RE, Quinn TC, Zenilman JM. Cost-effectiveness of five strategies for gonorrhea and chlamydia control among female and male emergency department patients. Sexually Transmitted Diseases 2002;29(2):83-91. [PUBMED: 11818893]
46. Meyers D, WolffT, Gregory K, Marion L, Moyer V, Nelson H, et al. USPSTF recommendations for STI screening. American Family Physician 2008;77(6):819-24. [PUBMED: 18386598]
47. Novak DP, Karlsson RB. Simplifying chlamydia testing: an innovative Chlamydia trachomatis testing approach using the internet and a home sampling strategy: population based study. SexuallyTransmitted Infections 2006;82(2):142-7; discussion 152-3. [PUBMED: 16581742]
48. Núñez-Forero, Moyano LF, Angel-Müller E, RodríguezA, Ruiz-Parra AI, Tolosa JE, et al. Diagnostic accuracy of rapid tests for C. Trachomatis, N. Gonorrhoeae and Syphilis at the point of care in women with symptoms of lower genital tract infection. International Journal of Gynaecology and Obstetrics 2012;119(S3):S350. [DOI: 10.1016/S0020-7292(12)60695-X]
49. Odesanmi TY, Wasti SP, Odesanmi OS, Adegbola O, Oguntuase OO, Mahmood S. Comparative effectiveness and acceptability of home-based and clinic-based sampling methods for sexually transmissible infections screening in females aged 14-50 years: A systematic review and meta-analysis. Sexual Health 2013;10(6):559-69. [PUBMED: 24160747]
50. Rager KM, Biro FM. Techniques of testing for sexually transmitted diseases. Current Women's Health Reports 2001;1(2):111-5. [PUBMED: 12112957]
51. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
52. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011.
53. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011.
54. Scott Lamontagne D, Baster K, Emmett L, Nichols T, Randall S, McLean L, et al. Incidence and reinfection rates of genital chlamydial infection among women aged 16-24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group. Sexually Transmitted Infections 2007;83(4):292-303. [PUBMED: 17050567]
55. Shih SL, Graseck AS, Secura GM, Peipert JF. Screening for sexually transmitted infections at home or in the clinic?. Current Opinion in Infectious Diseases 2011;24(1):78-84. [PUBMED: 21124216]
56. Smith KJ, Cook RL, Ness RB. Cost comparisons between home- and clinic-based testing for sexually transmitted diseases in high-risk young women. Infectious Diseases in Obstetrics and Gynecology 2007;2007:62467. [PUBMED: 18273404]
57. StataCorp LP. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP, 2013.
58. Ukoumunne OC, Gulliford MC, Chinn S, Sterne JA, Burney PG. Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review. Health Technology Assessment 1999;3(5):iii-92. [PUBMED: 10982317]
59. UNAIDS, WHO. Sexually transmitted diseases: policies and principles for prevention and care. UNAIDS best practice collection. Key material 1999.
60. USPSTF. Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine 2007;147(2):128-34. [PUBMED: 17576996]
61. Van Bergen J, Gotz H, Richardus JH, Hoebe C, Broer J, Coenen T. Prevalence of urogenital Chlamydia trachomatis infections in the Netherlands suggests selective screening approaches. Results from the PILOT CT Population Study. Drugs of Today 2006;42 Suppl A:25-33. [PUBMED: 16683041]
62. WHO, Department of Reproductive Health and Research. Guidelines for the management of sexually transmitted infections. Geneva, Switzerland: World Health Organization 2004.
63. WHO, Department of Reproductive Health and Research. Global strategy for the prevention and control of sexually transmitted infections 2006-2015. Breaking the chain of transmission. Geneva, Switzerland: World Health Organization 2005.
64. World Health Organization. Global incidence and prevalence of selected curable sexually transmitted infections - 2008. Geneva, Switzerland: World Health Organization 2012.
65. Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recommendations and Reports 2010 Dec 17;59 (RR-12):1-110. [PUBMED: 21160459]
66. Fajardo-Bernal L, Angel-Müller E, Aponte-Gonzalez J, Rincon C, Gaitán Hernando G, Low N. Home-based versus clinic-based management strategy for Chlamydia trachomatis and Neisseria gonorrhoeae. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2014, issue 9. [DOI: 10.1002/14651858.CD011317;: CD011317]